Five Products: Beyond Protein. The next wave of GLP-1 innovvation

Chevron Back

For a while, the GLP-1 conversation felt fairly predictable. Brands raced to launch protein shakes, high-fibre snacks and portion-controlled meals, all designed around consumers eating less. But the market is already moving on. As explored in the latest two-part Impact Makers Podcast series, GLP-1: Rewiring Consumption and GLP-1: What Happens Next?, the real opportunity now isn't simply feeding people differently. It's supporting the entirely new routines, side effects and sensory preferences that come with living on these medications. 

Consumers aren't just looking for more protein anymore. They're looking for products that replace lost micronutrients, protect their hair, improve gut health, tackle unexpected issues like "Ozempic breath" and even rethink how sweet food should taste. In other words, GLP-1 is no longer reshaping food. It's beginning to reshape FMCG. 

Here are five launches showing just how far the industry has already moved beyond the obvious. 

Five Products

1. NUTRILINQ Genesis Kit (US):

 NUTRILINQ has recently introduced a new Genesis Kit, one of the first supplement systems developed specifically for people taking GLP-1 medications. Rather than focusing on protein intake, the kit recognizes another challenge many users face: eating less can also mean consuming fewer essential vitamins and minerals. The system combines several targeted supplements formulated to help replace micronutrients that may lack during rapid weight loss while also supporting energy, muscle health, metabolism, and overall wellness. Instead of treating nutrition as a one-size-fits-all multivitamin, NUTRILINQ approaches GLP-1 support as a complete nutritional ecosystem designed around changing eating behaviors. 

2. M&S Nutrient Dense H5O Shot (U.K):

Part of M&S's UK "Nutrient Dense" range (launched January 2026), this is a concentrated botanical shot developed with scientists at the Royal Botanic Gardens, Kew, designed to help GLP-1 users hit micronutrient targets (vitamin D, iron, folate, B12) despite eating less — without leaning on a protein or fibre claim at all. It's a nice UK-market complement to your NUTRILINQ entry, and notably positioned discreetly (not badged as a "GLP-1 product" on pack) similar to how Nestlé is handling things quietly.

2
3

3. Biotène Moisturizing Spray (US):

Biotène has extended its dry-mouth range with its Moisturizing Spray as conversations around "Ozempic breath" continue to gain traction online. While dry mouth has long been associated with certain medications, an increasing number of GLP-1 users have begun discussing persistent dry mouth and unpleasant breath as unexpected side effects, creating entirely new opportunities within oral care. The Biotène Moisturizing Spray is designed to provide long-lasting moisture while helping freshen breath, by lubricating oral tissues to relieve dryness whenever symptoms occur throughout the day. Unlike traditional breath sprays that simply mask odor, Biotène focuses on treating one o

4. Nutrafol Women's Balance (US): 

Nutrafol has launched an expanded range of physician-formulated hair growth supplements as growing numbers of GLP-1 users report hair thinning following rapid weight loss. While "Ozempic face" has dominated headlines, hair loss is increasingly becoming another highly discussed side effect consumers are actively trying to manage. Nutrafol's portfolio includes Women's Balance, Women, Postpartum, Men's, and Vegan formulas, each combining ingredients such as marine collagen, botanical extracts, adaptogens, vitamins, and minerals designed to support healthier hair growth by addressing underlying causes rather than simply treating symptoms. Although not marketed exclusively for GLP-1 users, the brand has increasingly become part of conversations around medication-related hair thinning.  

4
5

5. resM Daily GLP-1 Postbiotic (US): 

ResBiotic has introduced resM Daily GLP-1 Postbiotic, one of the first gut-health supplements developed specifically for consumers taking GLP-1 medications. Instead of focusing solely on digestion, the daily supplement combines postbiotics with targeted ingredients designed to help maintain gut comfort, support the microbiome, and promote digestive resilience as the body adapts to the medication. The formulation also aims to help address common concerns reported by GLP-1 users, including bloating, constipation, and gastrointestinal discomfort. While gut-health products have become more popular over the past decade, this launch represents something different. Rather than offering general digestive wellness, it speaks directly to the changing physiological needs created by GLP-1 medications. 

If the first wave of GLP-1 innovation was about helping consumers eat less, then this next wave is definitely about helping them live differently. These launches suggest that the biggest opportunities won't necessarily sit in the protein aisle. They'll emerge wherever brands can solve the unintended consequences of appetite suppression, changing sensory preferences and new wellness routines. 

For FMCG’s, that means looking beyond the medication itself and understanding the everyday behaviors it's creating. The opportunity right now isn't simply another high-protein snack, it's the unmet needs consumers haven't even developed a language for yet. 

Want to explore where the GLP-1 conversation is heading next? Listen to the latest two-part Impact Makers Podcast episodes - GLP-1: Rewiring Consumption and GLP-1: What Happens Next? - where a team of experts unpack the emerging behaviors, product opportunities and innovation spaces that will shape the next chapter of FMCG.